Compared with WT BM-MSCs, transplantation of Rap1−/−-BM-MSCs achieved superior therapeutic efficacy in a mouse model of MI that may be attributed to Rap1-modulated cytokine bias and cell survival potential. Here, TERF2IP is linked to myocardial infarction.